From Survival Mode to Change Agent
A brain cancer survivor and Iowa business owner now leads executive philanthropy to raise millions of dollars for Duke’s brain tumor research.
Ojemda Preserves Quality of Life, Limits Cognitive Effects in Low-Grade Glioma
Duke science results in the first-ever FDA-approved therapy for the most common form of childhood brain cancer.
BEC Chairman Receives Presidential Volunteer Service Award
Tom Hickman is honored for his years of volunteer service and support.